HEREDITARY NEPHROGENIC DIABETES-INSIPIDUS RENALIS IN THE DOG .2. THERAPY

被引:0
作者
GRUNBAUM, EG
HERZOG, A
RASCHER, W
FAHRENHOLZ, F
LUZIUS, H
JANS, D
MORITZ, A
机构
[1] UNIV GIESSEN,INST TIERZUCHT & HAUSTIERGENET,D-35392 GIESSEN,GERMANY
[2] UNIV ESSEN GESAMTHSCH KLINIKUM,ZENTRUM KINDER & JUGENDMED,D-45147 ESSEN,GERMANY
[3] MAX PLANCK INST BIOPHYS,D-60596 FRANKFURT,GERMANY
来源
KLEINTIERPRAXIS | 1995年 / 40卷 / 07期
关键词
D O I
暂无
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
In this study canine hereditary nephrogenic diabetes insipidus in a family of huskies is reported (part 1 diagnosis). In this second part, the following methods of treatment were evaluated: treatment with a low-sodium, low-protein diet in addition to a low-sodium, low-protein diet hydrochlorothiazide (HCT) treatment, also combined with other drugs HCT and indomethacin treatment arginine-vasopressin and vasopressin agonists at high dosages long-term treatment with the vasopressin agonists dDAVP, dVSAVP, and SAVP The daily uptake of drinking water in the treated huskies was easily reduced by a mean value of 30 % without any risks by feeding a low-sodium, low-protein diet. A maximum reduction of the daily water uptake by 24,4 % was achieved with the usual HCT (Esidrix(R)) treatment, indomethacin treatment as well as the combination of both methods. A reduction of the water uptake by 60,2 % was managed by the combination of a low-sodium, low-protein diet, aminophylline, fludrocortisone, and potassium applications with HGT (Esidrix(R)). The use of the AVP agonist dDAVP (Minirin(R)), dVSAVP, and SAVP combined with a low-sodium, low-protein diet allowed a reduction of the daily water uptake by up to 70,38 %, depending on the dosage and the form of application.
引用
收藏
页码:501 / &
相关论文
共 50 条
  • [41] LITHIUM-INDUCED NEPHROGENIC DIABETES-INSIPIDUS
    JUHL, RP
    KRONFOL, Z
    TSUANG, MT
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1976, 33 (08): : 843 - 845
  • [42] CONGENITAL NEPHROGENIC DIABETES-INSIPIDUS - REPORT OF A CASE
    ZHANG, YM
    ZHANG, XX
    LI, XL
    CHINESE MEDICAL JOURNAL, 1985, 98 (10) : 775 - 778
  • [43] NEPHROGENIC DIABETES-INSIPIDUS REVEALING RETROPERITONEAL FIBROSIS
    GEPNER, P
    THALER, F
    BOTTO, H
    PIETTE, AM
    LOIRAT, P
    CHAPMAN, A
    REVUE DE MEDECINE INTERNE, 1993, 14 (02): : 112 - 114
  • [44] GRADIENT-TYPE NEPHROGENIC DIABETES-INSIPIDUS
    BRETSCHER, D
    BLUMBERG, A
    OETLIKER, O
    ARCHIVES OF DISEASE IN CHILDHOOD, 1977, 52 (05) : 422 - 422
  • [45] NEPHROGENIC DIABETES-INSIPIDUS (NDI) TREATED WITH INDOMETHACIN
    WINTERBORN, MH
    RAYNER, P
    SHAH, KJ
    PEDIATRIC RESEARCH, 1980, 14 (08) : 1008 - 1008
  • [46] CELLULAR PATHOGENESIS OF NEPHROGENIC DIABETES-INSIPIDUS IN MICE
    DOUSA, TP
    HOMMA, S
    VALTIN, H
    COFFEY, A
    RECENT PROGRESS IN POSTERIOR PITUITARY HORMONES 1988, 1988, 797 : 321 - 326
  • [47] PATHOGENESIS AND TREATMENT OF CONGENITAL NEPHROGENIC DIABETES-INSIPIDUS
    DUBOST, M
    BERTHEZENE, F
    POUSSET, G
    ORGIAZZI, J
    ACCOMINOTTI, JC
    ANNALES D ENDOCRINOLOGIE, 1976, 37 (04) : 313 - 314
  • [48] AZOTEMIA AND NEPHROGENIC DIABETES-INSIPIDUS AFTER ARTERIOGRAPHY
    KOVNAT, PJ
    LIN, KY
    POPKY, G
    RADIOLOGY, 1973, 108 (03) : 541 - 542
  • [49] MECHANISM OF URINARY CONCENTRATION IN NEPHROGENIC DIABETES-INSIPIDUS
    MCCONNELL, RF
    LORENTZ, WB
    BERGER, M
    SMITH, EH
    CARVAJAL, HF
    TRAVIS, LB
    PEDIATRIC RESEARCH, 1977, 11 (01) : 33 - 36
  • [50] OBSTRUCTIVE UROPATHY AND NEPHROGENIC DIABETES-INSIPIDUS IN INFANTS
    GIBBONS, MD
    KOONTZ, WW
    JOURNAL OF UROLOGY, 1979, 122 (04) : 556 - 559